TMEM173/STING1 was expressed higher in normal samples in lung adenocarcinoma, lung squamous carcinoma, prostate adenocarcinoma, uterine corpus endometrial carcinoma, but was expressed higher in tumor tissues in colorectal carcinoma, kidney renal clear cell carcinoma, stomach adenocarcinoma, and thyroid adenocarcinoma [81]. Here, STING1 is linked to uterine corpus endometrial carcinoma.